Yarrow Bioscience (YARW) Change in Acquisitions & Divestments (2017 - 2026)

Yarrow Bioscience (YARW) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $4.7 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 86.01% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.4 million (down 28.82% YoY) and the FY2025 annual result came in at $68.3 million, down 18.69% from the prior year.
• Change in Acquisitions & Divestments retreated to $4.7 million in Q1 2026, from $14.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $33.6 million in Q1 2025 to a low of $4.7 million in Q1 2026.
• A 3-year average of $19.5 million and a median of $22.9 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments surged 189.66% — and 2026, when it plunged 86.01%.
• Tracing YARW's Change in Acquisitions & Divestments over 3 years: stood at $22.9 million in 2024, then tumbled by 37.77% to $14.2 million in 2025, then plunged by 67.02% to $4.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $4.7 million (Q1 2026), $14.2 million (Q2 2025), and $33.6 million (Q1 2025), per Business Quant data.